Company news
Anika Therapeutics Inc. (NASDAQ:ANIK) news
Anika Therapeutics Inc. news releases on 6ix. Latest, Mar 27, 2023: Anika Files Preliminary Proxy Statement
Press releases — page 2
Anika Files Preliminary Proxy Statement
March 26, 2023
Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results
March 5, 2023
Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023
February 20, 2023
Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States
February 12, 2023
Anika Reports Third Quarter Fiscal 2022 Financial Results
November 7, 2022
Anika’s Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study
October 31, 2022
Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
October 24, 2022
Anika Announces First Surgeries Performed Using the X-Twist™ Fixation System and Commences Limited Market Release
September 11, 2022
Anika Reports Second Quarter Fiscal 2022 Financial Results
August 2, 2022
Anika to Issue Second Quarter 2022 Financial Results on Wednesday, August 3, 2022
July 11, 2022
Anika Receives FDA 510(k) Clearance for the X-Twist™ Knotless Fixation System, Expanding its Sports Medicine Soft Tissue Portfolio
May 19, 2022
Anika Reports First Quarter Fiscal 2022 Financial Results
May 4, 2022
Anika to Issue First Quarter 2022 Financial Results on Thursday, May 5, 2022
April 6, 2022
Anika Reports Fourth Quarter and Year-End 2021 Financial Results
March 7, 2022
Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022
February 7, 2022
Anika Reports Third Quarter 2021 Financial Results
November 3, 2021
Anika Appoints Sheryl Conley to Board of Directors
October 31, 2021
Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021
October 17, 2021
Anika Launches the WristMotion® Total Wrist Arthroplasty System at the American Society for Surgery of the Hand Annual Meeting
September 29, 2021
Tactoset® Injectable Bone Substitute Now FDA Cleared for Hardware Augmentation
September 13, 2021
Anika to Debut Joint Preservation Portfolio at the 2021 AAOS Annual Meeting
August 31, 2021
Anika Reports Second Quarter 2021 Financial Results
August 4, 2021
Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
July 18, 2021
First Anika WristMotion® Total Wrist Arthroplasty Surgery Performed
June 30, 2021
Anika Reports First Quarter 2021 Financial Results
May 5, 2021
Anika to Issue First Quarter 2021 Financial Results on Thursday, May 6, 2021
April 14, 2021
Anika Reports Fourth Quarter and Year-End 2020 Financial Results
March 3, 2021
Anika to Issue Fourth Quarter and Year-End 2020 Financial Results on Thursday, March 4, 2021
February 8, 2021
Anika Reports Third-Quarter 2020 Financial Results
November 3, 2020
Anika Announces FDA 510(k) Clearance for its WristMotion® Total Arthroplasty System for the Replacement of Painful Wrist Joints
October 20, 2020
Anika Announces Appointment of Jack Henneman and Stephen Richard to Board of Directors
September 7, 2020
Anika Appoints Michael Levitz as Chief Financial Officer
August 4, 2020
Anika Reports Second Quarter 2020 Financial Results
July 29, 2020
Anika To Launch Six FDA-Cleared Sports Medicine and Extremities Products in Third Quarter of 2020
July 19, 2020
Anika Announces Planned CFO Transition
June 1, 2020
Anika Reports First Quarter 2020 Financial Results
May 6, 2020
Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer
April 26, 2020
Anika to Issue First Quarter 2020 Financial Results and Business Highlights on Thursday, May 7
April 22, 2020
Anika Takes Actions to Strengthen Liquidity in Light of COVID-19
April 7, 2020
Anika Appoints David Colleran as General Counsel
March 3, 2020
Anika Reports Fourth Quarter and Full Year 2019 Financial Results
February 19, 2020
Anika Therapeutics Names Board Member Dr. Cheryl Blanchard as Interim CEO
February 11, 2020
CORRECTING and REPLACING Anika to Issue Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights on Thursday, February 20
February 5, 2020
Anika Therapeutics Closes Acquisition of Arthrosurface
February 2, 2020
Anika Therapeutics Mourns the Sudden Passing of Joseph Darling, President and Chief Executive Officer
January 28, 2020
Anika Therapeutics Closes Acquisition of Parcus Medical
January 23, 2020
Anika Therapeutics to Acquire Parcus Medical and Arthrosurface
January 5, 2020
Anika Commences Full U.S. Commercial Launch of TACTOSET Bone Repair Therapy at Orthopaedic Summit 2019: Evolving Techniques
December 9, 2019
Anika Therapeutics Announces Participation in MEDICA International Trade Fair and International Cartilage Regeneration and Joint Preservation Society Focus Meeting
November 14, 2019
Anika Reports Third Quarter 2019 Financial Results
October 23, 2019